Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma
出版年份 2021 全文链接
标题
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma
作者
关键词
-
出版物
Science Translational Medicine
Volume 13, Issue 577, Pages eaba7401
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-01-21
DOI
10.1126/scitranslmed.aba7401
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sustained hedgehog signaling in medulloblastoma tumoroids is attributed to stromal astrocytes and astrocyte-derived extracellular matrix
- (2020) Yan Cheng et al. LABORATORY INVESTIGATION
- Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
- (2020) Kyle S. Smith et al. ACTA NEUROPATHOLOGICA
- Functional precision medicine identifies new therapeutic candidates for medulloblastoma
- (2020) Jessica M Rusert et al. CANCER RESEARCH
- Predictors of Success of Phase II Pediatric Oncology Clinical Trials
- (2019) Laura Franshaw et al. ONCOLOGIST
- CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model
- (2019) Olivia Campagne et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells
- (2018) Katharina Krüger et al. CANCER LETTERS
- Development and validation of a sensitive LC MS/MS method for the measurement of the checkpoint kinase 1 inhibitor prexasertib and its application in a cerebral microdialysis study
- (2018) Bo Zhong et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
- (2018) Panagiotis Kotsantis et al. Cancer Discovery
- A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
- (2018) Raelene Endersby et al. NEOPLASIA
- A biobank of patient-derived pediatric brain tumor models
- (2018) Sebastian Brabetz et al. NATURE MEDICINE
- Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research
- (2017) John P. A. Ioannidis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Investigation of brain tissue infiltration by medulloblastoma cells in an ex vivo model
- (2017) Anuja Neve et al. Scientific Reports
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors
- (2016) Jeffrey R. Infante et al. CLINICAL CANCER RESEARCH
- In vitro models of medulloblastoma: Choosing the right tool for the job
- (2016) Delyan P. Ivanov et al. JOURNAL OF BIOTECHNOLOGY
- Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer
- (2016) David Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
- (2016) Eric W. Prince et al. Oncotarget
- Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
- (2015) Rebecca M. Hill et al. CANCER CELL
- RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors
- (2015) X. Zhao et al. CANCER RESEARCH
- LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models
- (2015) Darlene Barnard et al. INVESTIGATIONAL NEW DRUGS
- LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
- (2015) C. King et al. MOLECULAR CANCER THERAPEUTICS
- Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma
- (2014) Marie Morfouace et al. CANCER CELL
- Management of Pediatric and Adult Patients with Medulloblastoma
- (2014) Allison M. Martin et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Efficacy of cabazitaxel in mouse models of pediatric brain tumors
- (2014) Emily Girard et al. NEURO-ONCOLOGY
- Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
- (2013) Matija Snuderl et al. CELL
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor
- (2013) Constance King et al. INVESTIGATIONAL NEW DRUGS
- Subgroup-Specific Prognostic Implications ofTP53Mutation in Medulloblastoma
- (2013) Nataliya Zhukova et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors
- (2013) Todd M. Pitts et al. PHARMACOLOGY & THERAPEUTICS
- Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
- (2012) Adrian M. Dubuc et al. ACTA NEUROPATHOLOGICA
- An Animal Model of MYC-Driven Medulloblastoma
- (2012) Yanxin Pei et al. CANCER CELL
- Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma
- (2012) M. R. Russell et al. CANCER RESEARCH
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Nonredundant Functions for Akt Isoforms in Astrocyte Growth and Gliomagenesis in an Orthotopic Transplantation Model
- (2011) R. Endersby et al. CANCER RESEARCH
- CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog-Driven Medulloblastoma
- (2011) R. Sengupta et al. CANCER RESEARCH
- Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
- (2011) L. A. Parsels et al. CLINICAL CANCER RESEARCH
- The molecular classification of medulloblastoma
- (2011) Sarah E.S. Leary et al. CURRENT OPINION IN PEDIATRICS
- Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening
- (2011) T. J. Guzi et al. MOLECULAR CANCER THERAPEUTICS
- DNA replication as a target of the DNA damage checkpoint
- (2009) Philip Zegerman et al. DNA REPAIR
- Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
- (2009) Gregory T. Armstrong et al. JNCI-Journal of the National Cancer Institute
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
- (2008) N Bucher et al. BRITISH JOURNAL OF CANCER
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread
- (2008) B. A. Hatton et al. CANCER RESEARCH
- AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
- (2008) S. D. Zabludoff et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of DNA repair throughout the cell cycle
- (2008) Dana Branzei et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Classic and desmoplastic medulloblastoma: Complete case reports and characterizations of two new cell lines
- (2008) David J. Holthouse et al. NEUROPATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now